| 摘要 |
The present invention relates to the pharmaceutical uses of betaines for up- regulating, enhancing, stimulating, controlling and/or increasing constitutive nitric oxide synthase expression and endogenous nitric oxide production in a mammal, particularly in a human. Additionally, the betaines are claimed to augment after administration both immunological and functional (activity) expression of Tissue Factor Pathway Inhibitor (TFPI) in a mammal, particularly in a human. |
